日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Target-Centric Multiplexed Screening of an Herbal Extract Identifies a Novel Dual A(2A)/A(2B) Receptor Antagonist for Cancer Immunotherapy.

以目标为中心的多重筛选草药提取物,发现了一种用于癌症免疫疗法的新型双重 A(2A)/A(2B) 受体拮抗剂。

Liu Hongyue, Yang Xinyu, Xu Jingyi, Wang Yuefei, Zhao Zichen, Quan Ke, Gao Aoqi, Wang Yang, Wu Jingbo, Li Fei, Zhang Zhaoyu, Ma Yuanyuan, Weng Yuan, Chen Ying, Sun Liping, Song Gaojie, Shan Yibing, Chai Xin, Zhang Bingjie, Lu Weiqiang, Shui Wenqing

Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression

作者更正:PPIA 决定 NRF2 的稳定性以促进肺癌进展

Lu, Weiqiang; Cui, Jiayan; Wang, Wanyan; Hu, Qian; Xue, Yun; Liu, Xi; Gong, Ting; Lu, Yiping; Ma, Hui; Yang, Xinyu; Feng, Bo; Wang, Qi; Zhang, Naixia; Xu, Yechun; Liu, Mingyao; Nussinov, Ruth; Cheng, Feixiong; Ji, Hongbin; Huang, Jin

Cryo-EM structure of an activated GPR4-Gs signaling complex.

活化的GPR4-Gs信号复合物的冷冻电镜结构

Ma Yitong, Wang Yijie, Tang Mengyuan, Weng Yuan, Chen Ying, Xu Yueming, An Shuxiao, Wu Yiran, Zhao Suwen, Xu Huanhuan, Li Dali, Liu Mingyao, Lu Weiqiang, Ru Heng, Song Gaojie

Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cells

紫草素是一种新型的前列腺素E2受体4拮抗剂,靶向髓系来源的抑制细胞。

Wang, Yang; Abuduaini, Naijipu; Liu, Wenjuan; Song, Yuanjun; Ke, Zunping; Wang, Xilong; Jiao, Wei; Chen, Si; Lin, Xianhua; Yu, Weiwei; Lu, Weiqiang; Feng, Bo; He, Jiacheng

Naphthalene Diimide-Based Metallacage as an Artificial Ion Channel for Chloride Ion Transport

基于萘二酰亚胺的金属笼作为氯离子转运的人工离子通道

Ling, Qing-Hui; Fu, Yuanyuan; Lou, Zhen-Chen; Yue, Bangkun; Guo, Chenxing; Hu, Xinyu; Lu, Weiqiang; Hu, Lianrui; Wang, Wei; Zhang, Min; Yang, Hai-Bo; Xu, Lin

Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4

通过拮抗前列腺素E2受体4重塑胃癌治疗的免疫微环境

Guo, Mengmeng; Hu, Pan; Xie, Jiayi; Tang, Kefu; Hu, Shixiu; Sun, Jialiang; He, Yundong; Li, Jing; Lu, Weiqiang; Liu, Huirong; Liu, Mingyao; Yi, Zhengfang; Peng, Shihong

Structurally-informed human interactome reveals proteome-wide perturbations by disease mutations.

结构信息驱动的人类相互作用组揭示了疾病突变引起的蛋白质组范围的扰动

Xiong Dapeng, Qiu Yunguang, Zhao Junfei, Zhou Yadi, Lee Dongjin, Gupta Shobhita, Torres Mateo, Lu Weiqiang, Liang Siqi, Kang Jin Joo, Eng Charis, Loscalzo Joseph, Cheng Feixiong, Yu Haiyuan

Artificial Intelligence-Assisted Bioinformatics, Microneedle, and Diabetic Wound Healing: A "New Deal" of an Old Drug

人工智能辅助生物信息学、微针和糖尿病伤口愈合:旧药的“新政”

Yanan Xue, Cheng Chen, Rong Tan, Jingyu Zhang, Qin Fang, Rui Jin, Xiangyu Mi, Danying Sun, Yinan Xue, Yue Wang, Rong Xiong, Haojian Lu, Weiqiang Tan

Correction: METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way

更正:METTL3 以 m6A-YTHDF1 依赖的方式促进非小细胞肺癌 (NSCLC) 细胞增殖和克隆形成。

Dou, Xuejun; Wang, Zhiyuan; Lu, Weiqiang; Miao, Libin; Zhao, Yuefeng

Antiallergic drug desloratadine as a selective antagonist of 5HT(2A) receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction

抗过敏药物地氯雷他定作为5HT(2A)受体的选择性拮抗剂,可通过改善小胶质细胞功能障碍来减轻阿尔茨海默病模型小鼠的病理症状。

Lu, Jian; Zhang, Chuzhao; Lv, Jianlu; Zhu, Xialin; Jiang, Xingwu; Lu, Weiqiang; Lu, Yin; Tang, Zongxiang; Wang, Jiaying; Shen, Xu